Table: Brightpath Biotherapeutics -2017/18 parent results

BrightPath Biotherapeutics Co

11/05/2018 08:05

May 11 (Reuters)- 
          Brightpath Biotherapeutics Co., Ltd. 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to     NEXT     
              Mar 31, 2018    Mar 31, 2017   Mar 31, 2019     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales          354 mln         529 mln                               
               (-33.1 pct)     (-35.6 pct)                             
  Operating     loss 1.45       loss 1.09                              
  Recurring     loss 1.57       loss 1.09                              
  Net           loss 1.58       loss 1.11                              
  EPS        loss 41.25 yen  loss 32.74 yen                            
  Ann Div          NIL             NIL            NIL                  
  -Q2 Div          NIL             NIL            NIL                  
  -Q4 Div          NIL             NIL            NIL                  
  
  NOTE - Brightpath Biotherapeutics Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4594.T